Comparing complication rates in cataract surgery with different pre-operative treatments
Official title: Prospective Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative Standard of Care
Run by The Eye Centers of Racine and Kenosha · NCT06681688 · Data updated 2026-11-12
This study tests if a new combination of eye treatments before cataract surgery can lower the risk of complications compared to standard care.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 94 (estimated) |
| Sponsor | The Eye Centers of Racine and Kenosha Academic / other |
| Locations | 2 sites (Venice, Florida and 1 other locations) |
| Status | Recruiting |
| Started | July 10, 2024 |
| Main results expected | June 2025 |
| Study ends | August 2025 |
| Registry record updated | November 29, 2024 |
| Trial ID | NCT06681688 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old who are undergoing bilateral cataract surgery and are at higher risk for postoperative complications.
✕Probably not a fit
Patients undergoing cataract surgery combined with other procedures or those with glaucoma may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, randomized study evaluates the complication rates in patients undergoing bilateral cataract extraction. Participants will have one eye treated with a combination of pre-operative NSAIDs, OMIDRIA, and subconjunctival triamcinolone acetonide, while the fellow eye will receive standard of care treatments. The study aims to assess the effectiveness of the new treatment regimen compared to traditional methods in reducing postoperative complications. Patients will be monitored throughout the study for adherence to treatment and outcomes.
Why it matters
Potential benefit: If successful, this study could lead to improved postoperative outcomes and reduced complication rates for cataract surgery patients.
How similar studies have gone: Other studies have shown promising results with similar approaches, indicating potential for success in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult participants \> 18 years of age undergoing bilateral cataract surgery * Able to provide written informed consent prior to any study related procedure * Able and willing, as assessed by the Investigator, to follow study instructions, complete study assessments, comply with the protocol, and attend study visits for the duration of the study * Patients deemed to be "higher risk" for postoperative complications (e.g., well-controlled diabetes (HbA1c ≤7.0), history of uveitis, history of retinal vein occlusion, history of epiretinal membrane, history of vitreomacular traction, evidence of posterior synechiae, etc.) MAY be enrolled provided there has been no evidence of active disease or treatment in the prior 12 months * Participants who do not meet the exclusion criteria may be enrolled. Exclusion Criteria: * Cataract surgery combined with any other procedure (e.g., glaucoma, retina, etc.) * Glaucoma patients or known steroid responders * Oral anti-inflammatory medications to treat a systemic disease (exceptions to this include 81 mg aspirin, ibuprofen for headache, etc.) * Intraocular injection within 6 months * Any prior ocular implant * Diagnosis of retinal thickening in the study eye within 12 months of enrollment * Inability to provide informed consent * Participation in another clinical trial
Where it's running
-
The Eye Associates - Venice
Venice, Florida, United States Recruiting -
The Eye Centers of Racine & Kenosha
Racine, Wisconsin, United States Recruiting
Study contacts
- Principal investigator: Paul Singh, MD — The Eye Centers of Racine & Kenosha
- Study coordinator: Paul Singh, MD
- Email: ipsingh@amazingeye.com
- Phone: 262-637-0500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rotational Stability of the Acunex Vario Toric
This study tests whether the Acunex Vario toric extended-depth-of-focus intraocular lens stays stable in rotation and effectively reduces astigmatism for people undergoing cataract surgery.
-
Anterior segment anatomy assessment with swept-source OCT in eye surgery patients
This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.
-
MiLOOP-assisted cataract surgery for dense cataracts
In people with dense cataracts, this study tests whether using the miLOOP device during cataract surgery can protect corneal cells and reduce ultrasound energy, compared with standard surgery.
-
Visual adaptation and quality of life after different IOL implantation options
This study follows adults who have cataracts and receive bilateral multifocal or mixed IOLs to see how their vision and daily life improve over 6 months.
-
Corneal Biomechanics and Surgical Astigmatism after Cataract Surgery in Pseudoexfoliation
This study tests how the cornea's biomechanical properties before cataract surgery relate to the amount of blinking surgically induced astigmatism, comparing people with pseudoexfoliation to those without.
-
Neuroplastic pain education and guided breathing during awake cataract surgery
This trial tests whether the STEIN Protocol, a non-drug approach with pain education, guided imagery, and paced breathing, helps adults having cataract surgery require less pain medicine and feel less anxious.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.